<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/67B34D05-3A52-4A09-8FF9-F2398D60E246"><gtr:id>67B34D05-3A52-4A09-8FF9-F2398D60E246</gtr:id><gtr:name>University of Surrey</gtr:name><gtr:address><gtr:line1>Registry</gtr:line1><gtr:line2>Stag Hill</gtr:line2><gtr:line4>Guildford</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>GU2 7XH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/326EF7F4-5944-472D-BC94-2CA4484AEE74"><gtr:id>326EF7F4-5944-472D-BC94-2CA4484AEE74</gtr:id><gtr:name>University of Groningen</gtr:name><gtr:address><gtr:line1>Postbus 72</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/847CFDD6-585B-4103-BE2A-D48D56F5A7C8"><gtr:id>847CFDD6-585B-4103-BE2A-D48D56F5A7C8</gtr:id><gtr:name>University of Ghana</gtr:name><gtr:address><gtr:line1>Box LG 74</gtr:line1><gtr:line2>Legon</gtr:line2><gtr:line4>Accra</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Ghana</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A5CC1180-2386-42BD-B1A9-14DC84D52ED1"><gtr:id>A5CC1180-2386-42BD-B1A9-14DC84D52ED1</gtr:id><gtr:name>European Centre for Disease Prevention and Control (ECDC)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CE713D42-FE8A-4117-AB3C-224D5A93265A"><gtr:id>CE713D42-FE8A-4117-AB3C-224D5A93265A</gtr:id><gtr:name>Heinrich Heine University D?sseldorf</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:department>Molecular &amp; Clinical Sci Research Inst</gtr:department><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F325BF32-08AE-4621-8057-E5D6613B7308"><gtr:id>F325BF32-08AE-4621-8057-E5D6613B7308</gtr:id><gtr:name>St George's University of London</gtr:name><gtr:address><gtr:line1>Cranmer Terrace</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW17 0RE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/67B34D05-3A52-4A09-8FF9-F2398D60E246"><gtr:id>67B34D05-3A52-4A09-8FF9-F2398D60E246</gtr:id><gtr:name>University of Surrey</gtr:name><gtr:address><gtr:line1>Registry</gtr:line1><gtr:line2>Stag Hill</gtr:line2><gtr:line4>Guildford</gtr:line4><gtr:line5>Surrey</gtr:line5><gtr:postCode>GU2 7XH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/326EF7F4-5944-472D-BC94-2CA4484AEE74"><gtr:id>326EF7F4-5944-472D-BC94-2CA4484AEE74</gtr:id><gtr:name>University of Groningen</gtr:name><gtr:address><gtr:line1>Postbus 72</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/847CFDD6-585B-4103-BE2A-D48D56F5A7C8"><gtr:id>847CFDD6-585B-4103-BE2A-D48D56F5A7C8</gtr:id><gtr:name>University of Ghana</gtr:name><gtr:address><gtr:line1>Box LG 74</gtr:line1><gtr:line2>Legon</gtr:line2><gtr:line4>Accra</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Ghana</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A5CC1180-2386-42BD-B1A9-14DC84D52ED1"><gtr:id>A5CC1180-2386-42BD-B1A9-14DC84D52ED1</gtr:id><gtr:name>European Centre for Disease Prevention and Control (ECDC)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/99A20F70-F6B7-43DE-94E4-7004FAE6291E"><gtr:id>99A20F70-F6B7-43DE-94E4-7004FAE6291E</gtr:id><gtr:name>Ludwig Maximilians University Munich</gtr:name><gtr:address><gtr:line1>Geschwister-Scholl-Platz 1</gtr:line1><gtr:postCode>D-80539</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/57150975-2FFC-442F-A99E-ABD25A46F8D2"><gtr:id>57150975-2FFC-442F-A99E-ABD25A46F8D2</gtr:id><gtr:name>Pasteur Institute, Paris</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CE713D42-FE8A-4117-AB3C-224D5A93265A"><gtr:id>CE713D42-FE8A-4117-AB3C-224D5A93265A</gtr:id><gtr:name>Heinrich Heine University D?sseldorf</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/54E2DC31-E160-4524-B407-E4F5706B96C9"><gtr:id>54E2DC31-E160-4524-B407-E4F5706B96C9</gtr:id><gtr:firstName>Mark</gtr:firstName><gtr:otherNames>Harding</gtr:otherNames><gtr:surname>Wansbrough-Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C7596ECF-9FBE-46B6-B1D0-9FD7F74A911C"><gtr:id>C7596ECF-9FBE-46B6-B1D0-9FD7F74A911C</gtr:id><gtr:firstName>Richard</gtr:firstName><gtr:otherNames>Odame</gtr:otherNames><gtr:surname>Phillips</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FJ01477X%2F1"><gtr:id>FDCF9C51-CF49-40C8-8973-F14C18612AE6</gtr:id><gtr:title>R Phillips, KNUST Ghana. Pathogenesis and management of M. ulcerans disease, Buruli ulcer</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/J01477X/1</gtr:grantReference><gtr:abstractText>Buruli ulcer is a neglected tropical disease caused by infection with Mycobacterium ulcerans (Mu) which is common in rural parts of West African countries including Ghana. It causes large, disfiguring skin ulcers mainly in children aged 5 to 15 years although any age can be affected. Access to treatment in rural areas is limited and many cases present late because of fear, suspicion about conventional medicine and the economic consequences for poor families. The disease is highly focal and in Ghana, where these investigations will be carried out, it is not seen at all in the North, most cases occurring in particular parts of the Ashanti Region. The mode of transmission remains unknown but there have been major advances in understanding the mechanism of disease since the establishment of the WHO Buruli ulcer initiative in 1998 together with improved diagnosis and management. The aim of the proposed studies is to identify markers predictive of a rapid response to antibiotic treatment and to investigate the pathogenesis of paradoxical reactions and oedematous lesions in Mu disease.
When someone is infected with Mu, the first sign is a nodule under the skin which gradually enlarges and breaks down in the centre to form an ulcer. This is because Mu produces a toxin that spreads outwards and damages subcutaneous tissue. In about 15% of cases the skin around the ulcer is swollen with oedema, that is fluid in the tissue, and in this situation the ulcer enlarges more rapidly so that it may involve a whole limb for example.
In recent years it has been found that instead of removing ulcers by extensive surgery it is possible to heal them by antibiotic treatment for 8 weeks with daily tablets and intramuscular injections. This is unpleasant, particularly for children, and it would be better if the treatment could be limited to a shorter time. Our previous studies suggest that it may be possible to do investigations at the beginning of treatment that distinguish people who need only 4 weeks antibiotic treatment. A wide range of tests will be investigated in detail to identify markers for people in whom the infection is at an early stage with low numbers of the Mu bacteria and low levels of the toxin in the skin. During antibiotic treatment the rate of healing will be measured carefully to find out which markers are most reliable and practical for use in countries where Buruli ulcer is endemic.
After antibiotic treatment some patients develop new areas of inflammation or a sudden increase in the size of a healing ulcer, giving the impression that the infection is still active. It is not known what causes these paradoxical reactions but it is thought that there is an increasing immune response to residual dead Mu organisms in the tissue. In the proposed studies the immune response to Mu will be investigated serially during antibiotic treatment and when patients develop a paradoxical reaction. 
Oedematous disease is the most severe form of Buruli ulcer. The cause of it is not known but a likely explanation is that larger than normal amounts of the Mu toxin mycolactone are produced and diffuse away from the initial site of infection. This will be investigated by measuring mycolactone in the skin of patients and studying mycolactone production by the strain of Mu cultured from patients with this form of the disease.</gtr:abstractText><gtr:technicalSummary>Buruli ulcer is a neglected tropical disease caused by infection with Mycobacterium ulcerans (Mu) which is common in remote rural parts of West African countries including Ghana. The disease results initially in a subcutaneous painless nodule tethered to the skin or an intradermal plaque both of which ulcerate centrally. Oedematous disease is the most severe form of disease and it occurs in about 15% of cases. It may extend to a whole limb. 
Antibiotic treatment with rifampicin and streptomycin for 8 weeks is now standard. The main aim of the proposed studies is to investigate markers for patients with early infection in whom the bacterial load is low and production of the M. ulcerans toxin mycolactone is limited. It is proposed that such patients will respond rapidly to antibiotic treatment and that a shortened course of antibiotics will be adequate. 
A prospective observational study will be undertaken in patients diagnosed accurately to have Mu infection. Biomarkers will be investigated in serum using multianalyte profiling by Luminex. The immune response to Mu antigens will be studied and lymphocyte populations will be analysed by flow cytometry. Tissue mycolactone concentration will be measured by a cytotoxicity assay and by mass spectrometry.
Paradoxical reactions are seen in 10% of cases during or after antibiotic treatment. The pathogenesis of these reactions and of oedematous disease will be investigated using the same techniques to measure the immune response to Mu antigens, serum biomarkers and tissue mycolactone concentration.</gtr:technicalSummary><gtr:potentialImpactText>The results of this research will be made available to the Buruli ulcer community including scientists studying the disease and health workers of all levels. The potential benefits are that patients will receive better informed management in the future and in particular it may be possible to shorten the course of antibiotic treatment with consequent savings in resources as well as reduced discomfort for patients. The management of paradoxical reactions and oedematous disease may improve as a result of knowledge acquired during the investigation.
The research will be largely carried out in Ghana where Buruli ulcer is endemic and there will be benefits in the development of infrastructure and capacity building.
The African Research Leader will acquire new knowledge and skills that will enable him to compete in obtaining funding for future research. Support during the tenure of the award will allow him to continue building a team of researchers in Kumasi. The link between KNUST and SGUL will be strengthened and new research ideas will be generated at both institutions.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-07-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-01-02</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>454041</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Fluorescent TLC collaboration for mycolactone detection (Harvard)</gtr:description><gtr:id>1535AAC0-282D-4475-B7B5-48948CAAF81A</gtr:id><gtr:impact>1. Publication of initial analysed data on fTLC assay in Plos NTD journal 
2. Providing ongoing training and technical support in the field evaluation of the fTLC assay</gtr:impact><gtr:outcomeId>56c9dc419c3262.32268773-1</gtr:outcomeId><gtr:partnerContribution>Training of Michael Frimpong who is a member of our group in the fTLC technique in detection of mycolactone
Providing technical advice on the fTLC method of detection of mycolactone</gtr:partnerContribution><gtr:piContribution>Recruitment, follow up and providing well characterized patient samples for optimization of the fTLC assay</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Southampton</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Southampton proteomic collaboration</gtr:description><gtr:id>9BC9B4DB-42AE-417A-87E3-D4443D804440</gtr:id><gtr:impact>1.Dr Michael Frimpong from my group obtained training in the bioinformatics aspect of the proteomics technology in 2015
2. Samples processed by multiplex iTRAQ LC-MS mass spectrometry (analysis of data ongoing)</gtr:impact><gtr:outcomeId>56c9d8a6c31dc7.24990735-1</gtr:outcomeId><gtr:partnerContribution>1. Processed serum and tissue samples by state of the art multiplex iTRAQ LC-MS mass spectrometry. 
2. Training of team in the bioinformatics aspect of the proteomics technology</gtr:partnerContribution><gtr:piContribution>Recruitment of patients with Buruli ulcer and obtaining tissue and serum samples.
Providing clinical input on the study participants</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Pasteur Institute metabolomic collaboration</gtr:description><gtr:id>1CFD7EB2-0B2E-45A0-8138-BFABA0974E65</gtr:id><gtr:impact>Data from this work has been already been published in Scientific Reports Journal
1. doi: 10.1371/journal.pntd.0002786. PubMed PMID: 24722524; PubMed Central PMCID: PMC3983110.
2.doi: 10.12968/jowc.2014.23.8.417. Erratum in: J Wound Care. 2014 Dec;23(12):642. PubMed PMID: 25139600.
3.doi: 10.1038/srep17693. PubMed PMID: 26634444; PubMed Central PMCID: PMC4669498.</gtr:impact><gtr:outcomeId>56c9da65aaf862.94585393-1</gtr:outcomeId><gtr:partnerContribution>Running and analysis of serum samples by the metabolomics approach to determine metabolic markers associated with Buruli ulcer</gtr:partnerContribution><gtr:piContribution>Recruitment and providing well-characterised patient samples for metabolomic analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Groningen</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Buruli ulcer management study</gtr:description><gtr:id>1208DC83-03F8-48AB-88AD-53488C16117E</gtr:id><gtr:impact>Publications:
1. doi: 10.1371/journal.pntd.0002739. PubMed PMID: 24625583; PubMed Central PMCID: PMC3953024.
2. doi: 10.1097/QAD.0000000000000146. PubMed PMID: 24979651.
3. doi: 10.1371/journal.pntd.0002964. PubMed PMID: 25010061; PubMed Central PMCID: PMC4091870.
4. doi: 10.4269/ajtmh.14-0405. PubMed PMID: 25331802; PubMed Central PMCID: PMC4347364.
5. doi: 10.1371/journal.pntd.0003303. Erratum in: PLoS Negl Trop Dis. 2014 Dec;8(12):e3418. Stientstra, Ymkje [corrected to Stienstra, Ymkje]. PubMed PMID: 25392915; PubMed Central PMCID: PMC4230927.. 
6. doi: 10.1371/journal.pntd.0003254. PubMed PMID: 25393289; PubMed Central PMCID: PMC4230837.
7. doi: 10.1371/journal.pone.0119926. PubMed PMID: 26030764; PubMed Central PMCID: PMC4451111. 
8. doi: 10.1371/journal.pntd.0004076. PubMed PMID: 26402069; PubMed Central PMCID: PMC4581868. 
9. doi: 10.1371/journal.pntd.0004594. PubMed PMID: 27097163; PubMed Central PMCID: PMC4838240.
10. doi: 10.1016/j.ijmyco.2016.02.004. PubMed PMID: 27242237.
11. PubMed PMID: 27621302; PubMed Central PMCID: PMC5094208.
12. doi: 10.1371/journal.pntd.0005261. PubMed PMID: 28033343; PubMed Central PMCID: PMC5226828. 
13.</gtr:impact><gtr:outcomeId>58baaf7caa2763.66628049-1</gtr:outcomeId><gtr:partnerContribution>Training in workshops</gtr:partnerContribution><gtr:piContribution>I am co principal investigator in studies set up to investigate the efficacy of full oral antibiotic (rifampicin and clarithromycin) versus rifampicin and the injection streptomycin. Our group has been central to its design and implementation. We recruited patients at 4 of our treatment sites and have treated and followed them up.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Centre for Disease Prevention and Control (ECDC)</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:description>Cellular immune response to M. ulcerans specific antigens</gtr:description><gtr:id>2ACDF5B2-1567-41CE-88DD-581550F04A9C</gtr:id><gtr:impact>Public Health
Internal Medicine
Laboratory sciences
Study ongoing</gtr:impact><gtr:outcomeId>54637f94c610f9.76727510-1</gtr:outcomeId><gtr:partnerContribution>supply of specific M ulcerans antigens</gtr:partnerContribution><gtr:piContribution>Recruitment and follow up of patients with M ulcerans diseases as well as testing of the immune response to specific M ulcerans antigens.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Development of WASp assay for mycolactone</gtr:description><gtr:id>0BD9D8CD-2A9C-41FC-9622-A9FFD7AEBB3E</gtr:id><gtr:impact>None so far</gtr:impact><gtr:outcomeId>54510ca6565af1.22193415-1</gtr:outcomeId><gtr:partnerContribution>Provision of peptides and labelled mycolactone plus expertise</gtr:partnerContribution><gtr:piContribution>Developing assay for use with human samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Heinrich Heine University D?sseldorf</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Buruli ulcer coinfection study</gtr:description><gtr:id>4233630C-E705-416C-A0DC-99FBC43E589B</gtr:id><gtr:impact>Publications include:
1. doi: 10.3201/eid2006.131501. PubMed PMID: 24857346; PubMed Central PMCID: PMC4036786.
2. doi: 10.1186/s13071-016-1960-0. PubMed PMID: 28061905; PubMed Central PMCID: PMC5219801.
3. doi: 10.1371/journal.pntd.0005415.</gtr:impact><gtr:outcomeId>58baacfc7c3486.75634349-1</gtr:outcomeId><gtr:partnerContribution>Provided mentoring and training for group members
Equipment
Expertise in the laboratory</gtr:partnerContribution><gtr:piContribution>As co principal investigator the goal of this collaboration is to determine the immune response in patients with mycobacterial disease and coinfection with filarial worms Mansonella perstans. Our team was involved in study design, and implementation. Our activities included patient recruitment, diagnosis confirmation, management, sample collection, analysis, immunological assays, clinical trials and entomological studies.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ludwig Maximilian University of Munich (LMU Munich)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Implementation of viability testing for M ulcerans</gtr:description><gtr:id>D7A7668E-ADCD-4657-BDD0-9A6D308E5AE4</gtr:id><gtr:impact>Work in progress..
Disciplines:
Public health
Internal medicine
Laboratory science

Publications: 
1. doi: 10.1371/journal.pntd.0004219. PubMed PMID: 26566026; PubMed Central PMCID: PMC4643924. 
2. doi:10.4172/2329891X.1000158
3. doi: 10.1371/journal.pntd.0003457. PubMed PMID: 25569674; PubMed Central PMCID: PMC4287572.
4. doi: 10.3201/eid2006.131501. PubMed PMID: 24857346; PubMed Central PMCID: PMC4036786
5. doi: 10.1128/JCM.03119-13. PubMed PMID: 24478404; PubMed Central PMCID: PMC3993512.
6.doi:10.1371/journal.pntd.0001756</gtr:impact><gtr:outcomeId>5463822f3789a2.17559385-1</gtr:outcomeId><gtr:partnerContribution>Provision of expertise and optimisation of the 16srRNA assay</gtr:partnerContribution><gtr:piContribution>Recruitment of patients with M ulcerans disease
Setting up 16srRNA assay at the KCCR at KNUST</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Ghana</gtr:collaboratingOrganisation><gtr:country>Ghana, Republic of</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Fluorescent TLC collaboration for mycolactone detection (Accra)</gtr:description><gtr:id>4D532245-C7F9-420B-AB86-0493D2B4534A</gtr:id><gtr:impact>1. Fluorescent TLC equipment already set up and running</gtr:impact><gtr:outcomeId>56c9ddebb918a8.30431150-1</gtr:outcomeId><gtr:partnerContribution>Setting up of the fTLC equipment at the Kumasi Centre for Collaborative Research (KCCR) at KNUST
Running fTLC analysis on patient urine samples</gtr:partnerContribution><gtr:piContribution>Recruitment and providing patient samples for detection of mycolactone in urine by the fTLC assay
Performing molecular analysis of samples from Buruli ulcer patients</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pasteur Institute, Paris</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Department of Immunology</gtr:department><gtr:description>Multi-analyte profiling of serum samples from patients with Buruli ulcer</gtr:description><gtr:id>CE7F71D4-25DC-470C-88B8-A90D16918C99</gtr:id><gtr:impact>1: Niang F, Sarfo FS, Frimpong M, Guenin-Mac&amp;eacute; L, Wansbrough-Jones M, Stinear T,
Phillips RO, Demangel C. Metabolomic profiles delineate mycolactone signature in 
Buruli ulcer disease. Sci Rep. 2015 Dec 4;5:17693. doi: 10.1038/srep17693. PubMed
PMID: 26634444; PubMed Central PMCID: PMC4669498.


2: Phillips RO, Sarfo FS, Landier J, Oldenburg R, Frimpong M, Wansbrough-Jones M,
Abass K, Thompson W, Forson M, Fontanet A, Niang F, Demangel C. Combined
inflammatory and metabolic defects reflected by reduced serum protein levels in
patients with Buruli ulcer disease. PLoS Negl Trop Dis. 2014 Apr 10;8(4):e2786.
doi: 10.1371/journal.pntd.0002786. eCollection 2014 Apr. PubMed PMID: 24722524;
PubMed Central PMCID: PMC3983110.


3: Phillips R, Sarfo FS, Guenin-Mac&amp;eacute; L, Decalf J, Wansbrough-Jones M, Albert ML, 
Demangel C. Immunosuppressive signature of cutaneous Mycobacterium ulcerans
infection in the peripheral blood of patients with buruli ulcer disease. J Infect
Dis. 2009 Dec 1;200(11):1675-84. doi: 10.1086/646615. PubMed PMID: 19863437.</gtr:impact><gtr:outcomeId>qJ5sXrKxM2q-1</gtr:outcomeId><gtr:partnerContribution>Multi-analyte profiling</gtr:partnerContribution><gtr:piContribution>Provision of patient serum samples</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Surrey</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>University of Surrey Coagulation study</gtr:description><gtr:id>551BBC55-8491-42DA-9C7F-532D195DA738</gtr:id><gtr:impact>1 Publication: doi: 10.1111/cmi.12547. Review. PubMed PMID: 26572803; PubMed Central PMCID: PMC4705457</gtr:impact><gtr:outcomeId>58baa747c18295.64468308-1</gtr:outcomeId><gtr:partnerContribution>To provide further training for group members including training of 1 PhD candidate. To provide co-mentoring for team members.
To contribute equipment and new assay techniques</gtr:partnerContribution><gtr:piContribution>As co- principal investigator on a study funded by the Wellcome Trust Senior Investigator Awarded to Dr Rachel Simmonds of University of Surrey, we will fully explore the role of haemostasis (blood clotting) in the pathogenesis of BU, by focusing on endothelial dysfunction caused by mycolactone. One of my group members will be trained on this project. We contributed to study design, planning and implementation of the study in Ghana. We are involved in patient recruitment, management and follow-up. Other activities include assessment of patients for inclusion in the study, diagnostic confirmation and initial coagulation testing on blood samples. We will contribute samples for further assays in London.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Speaker opportunity</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EFC724C1-CDD3-406C-9E04-2DC33FF05B34</gtr:id><gtr:impact>The talk stimulated questions and discussion

After the meeting some members of the audience expressed interest to collaborate with the Network of African Researchers in Neglected Tropical Diseases (ARNTD)</gtr:impact><gtr:outcomeId>545f66cd9e06f0.00550937</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Grand Challenges Annual Meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A81645C1-F6D0-45BF-8D28-21FF0271A567</gtr:id><gtr:impact>Invited to participate in workshops on &amp;quot;Building a Strong Research Ecosystem for Sustainable Development track&amp;quot;. Views provided in the workshops were compiled and would contribute to the African Grand Challenges Funding programme.</gtr:impact><gtr:outcomeId>58ba90eabdd328.07248903</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>St George's University Seminar</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>34CF9D03-718C-4B7F-BC10-1071891A74C1</gtr:id><gtr:impact>Spoke at the seminar meeting for the infection and Immunity institute at St George's University of London on the topic New insights for treatment of Buruli ulcer 
There were lots of questions and discussion.</gtr:impact><gtr:outcomeId>56c9e49c0f4833.74172334</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Diploma in Tropical Medicine and Hygiene Course (DTM&amp;H) talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>172CB9BB-5D26-4173-9EF5-C5A1CD8BD35C</gtr:id><gtr:impact>Talked at the Diploma in Tropical Medicine and Hygiene Course (DTM&amp;amp;H) on Buruli ulcer. The lecture sparked lots of discussions and the school requested that I return to do the talk in 2016</gtr:impact><gtr:outcomeId>56c9e34b3f77e4.13625961</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Referee opportunity</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B5688B98-4787-4975-8BF8-F3E70070D6C5</gtr:id><gtr:impact>Joined the AREF college of experts to the review applications for the newly instituted Africa Research Development Fellowships 2015</gtr:impact><gtr:outcomeId>56c9e11b827a18.00056416</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>WHO-FIND consultative meeting attendance</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>508C75E8-3B06-42E8-926A-921C08B6C0C8</gtr:id><gtr:impact>There were lots of questions and discussions

There was consensus to further develop mycolactone detection assays for Buruli ulcers</gtr:impact><gtr:outcomeId>545f6aade30098.00425066</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>German-African Cooperation Projects meeting attendance</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3BBDAA22-BFA5-4BF9-B691-FEA766598103</gtr:id><gtr:impact>Invited by the German Research Foundation to speak on the &amp;quot;African Research Network into Neglected Tropical Diseases (ARNTD)&amp;quot; a network of post doctoral research scientists in Africa working to: 
Promote NTD research and control in Africa through advocacy and resource mobilization, 
Stimulate and strengthen research capacity in Africa, 
Create a sustainable collaborative network between researchers, policy makers and implementers in Africa, 
Disseminate evidence based information on NTDs at all levels of the health care system
This talk sparked questions and there was very positive feedback</gtr:impact><gtr:outcomeId>56c9e284695981.45026501</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Stakeholder meeting attendance</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0D1B4E79-BF27-4F1C-AC9D-797C70E8A77A</gtr:id><gtr:impact>There were lot of questions and discussions afterward

Two further meetings have been held with officials of EDCTP subsequently in July 2014 (Berlin) and October 2014 (Hamburg).
Fellows of the EDCTP working in the area of NTDs were invited and participated in a meeting of African Researchers in NTDs in Hamburg 2014.</gtr:impact><gtr:outcomeId>545f69f49a3fa7.64616750</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Pain conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B78AB55D-A71A-4131-863B-D08228C5BA0C</gtr:id><gtr:impact>Invited to present on management of pain associated with Buruli ulcer treatment held at Agogo hospital. This meeting was organised with team from the University of Groningen in the Netherlands. There were lots of discussions and a draft protocol for pain management was developed.</gtr:impact><gtr:outcomeId>56cb0f33e107f7.33762662</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B3D75153-7EEB-4226-B5E7-EAAE6031A5DE</gtr:id><gtr:impact>There were questions and discussion afterwards

After my talk the school expressed the desire for me to do similar talks on their course every year.</gtr:impact><gtr:outcomeId>545f682be61473.08146139</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Grant writing workshop attendance</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>1489B9A9-803F-4060-AE9B-25DE6E2C0AD7</gtr:id><gtr:impact>Invited by the Research and Grants office of the KNUST to join other Senior Scientists of the University to provide training for Lecturers and Researchers on &amp;quot; Attracting Research Funds through proposal writing&amp;quot;. This was well attended with lot of positive feedback and discussions</gtr:impact><gtr:outcomeId>56c9e1cfa86589.24570195</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Follow-up Conference for German- African Cooperation projects in Infectology, Yaounde Cameroun</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>53375EB6-485D-4408-9748-BF49E7D80DAF</gtr:id><gtr:impact>Invited to present on &amp;quot;The effects of Mansonella perstans on concomitant mycobacterial infections in Ghana&amp;quot; as weel as &amp;quot;An analysis of immune responses in Buruli ulcer patients&amp;quot;. This sparked a lot of discussions and interest. I have subsequently been invited to present in a similar meeting in 2017.</gtr:impact><gtr:outcomeId>58ba8d2c5ed691.25135026</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop on Effective Teaching, Proposal Writing and Manuscript Writing</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>55C10F55-C1F1-41A6-AF00-8D6DD90CBCE2</gtr:id><gtr:impact>Invited by the Faculty of Allied Health Sciences at the Kwame Nkrumah University of Science and Technology as facilitate at a workshop on
&amp;quot;Proposal writing&amp;quot;, &amp;quot;How to publish in peer review journals&amp;quot; and &amp;quot;How to review research articles&amp;quot;. This was very interactive and feedback was excellent. Provided mentorship for some of the faculty members after the workshop.</gtr:impact><gtr:outcomeId>58ba8f71db9a79.69693831</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>115840</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>American leprosy Mission</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>American Leprosy Mission</gtr:fundingOrg><gtr:id>8AF4D35F-DA66-4775-9454-9C42E259C632</gtr:id><gtr:outcomeId>56c9def4160969.42631929</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6280</gtr:amountPounds><gtr:country>Sweden, Kingdom of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sorbact, ABIGO Medical AB grant</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>ABIGO Medical AB</gtr:fundingOrg><gtr:id>DA3B7ADF-45AA-43C3-BD28-C76D63AED4F3</gtr:id><gtr:outcomeId>56c9e00c685948.67204978</gtr:outcomeId><gtr:sector>Multiple</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>404000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>German-African Cooperation Projects in Infectology</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>German Research Foundation (DFG)</gtr:fundingOrg><gtr:id>C58DD149-B149-4E6D-A6DB-685743884D9C</gtr:id><gtr:outcomeId>545f61fb33fa23.79517862</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Chronic HCV study</gtr:description><gtr:end>2016-05-02</gtr:end><gtr:fundingOrg>Loyola University Medical Center</gtr:fundingOrg><gtr:id>A5B5358F-B5CF-415D-93C7-FCCF89AB373A</gtr:id><gtr:outcomeId>58baa2254580f7.96872347</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>49790</gtr:amountPounds><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:department>Special Programme for Research and Training in Tropical Disease</gtr:department><gtr:description>WHO/ TDR, the Special Programme for Research and Training in Tropical Diseases co sponsored by UNICEF, UNDP, the World Bank and WHO Impact Award 2015</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>World Health Organization (WHO)</gtr:fundingOrg><gtr:fundingRef>2016/665689-0</gtr:fundingRef><gtr:id>9F6442E8-AB7A-4122-A423-A2FDCB16B2E8</gtr:id><gtr:outcomeId>58ba8817db7290.39690923</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>70900</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Senior Investigator Award</gtr:department><gtr:description>Wellcome Trust Senior Investigator Award to Dr Rachel Simmonds of University of Surrey.</gtr:description><gtr:end>2020-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>39B97294-8EFC-4325-977E-DA6998DF5C56</gtr:id><gtr:outcomeId>58baa0cfb01b63.68158186</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Ghana National Buruli ulcer Steering Committee meeting</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>370432A6-A429-43B4-9C86-B3CD582766F7</gtr:id><gtr:impact>This leads to an improvement in case finding and management in Ghana</gtr:impact><gtr:outcomeId>56cb1062964879.18107726</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participation in WHO Regional Programme Review Group (RPRG) meeting</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>AA99F60F-E02A-4305-8FDF-C30A2918405B</gtr:id><gtr:impact>Advocated for the adoption of the integrated strategy against case management- neglected tropical diseases. Attending programme managers for countries drew initial plans to adopt this new strategy.</gtr:impact><gtr:outcomeId>58ba9c06c4fd85.38451844</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Management Board member of African Research Network on Neglected Tropical Diseases (ARNTD)</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>101CFDBF-D053-4149-AC7D-564C6DEE83C9</gtr:id><gtr:impact>As a member of the Management Board for ARNTD we have been influential in shaping the discussion on NTDs. ARNTD supports evidence-based control and elimination of NTDs from Africa by empowering current generation of African researchers. ARNTD has been involved in advocacy and have provided a collaborative Network between researchers, policy makers and implementers working towards an Africa free of NTDs.</gtr:impact><gtr:outcomeId>58babf3f401743.22325295</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type><gtr:url>http://arntd.org/</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Development of Standard Operating Practices for Buruli ulcer care</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>002B9D9D-DD37-45C0-BA7F-D779BFB95292</gtr:id><gtr:outcomeId>56cb110510d619.00145524</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D4830540-46EF-474C-937E-DD82B5B7C65A</gtr:id><gtr:title>Comparison of two assays for molecular determination of rifampin resistance in clinical samples from patients with Buruli ulcer disease.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ff45642f7a5434862a9ea70b08268fd"><gtr:id>6ff45642f7a5434862a9ea70b08268fd</gtr:id><gtr:otherNames>Jansson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>545f4e70051010.55856360</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6485B2A-8724-4F82-988F-BB75B1FAEB6A</gtr:id><gtr:title>Factors associated with D-dimer levels in HIV-infected individuals.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a6260a796dc8f5e490c4fd0383c77b53"><gtr:id>a6260a796dc8f5e490c4fd0383c77b53</gtr:id><gtr:otherNames>Borges AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_23409_29_24626096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A2D69AD-5AA4-4998-AA47-9ED67F4B8DC6</gtr:id><gtr:title>Analysis of Mycobacterium ulcerans-specific T-cell cytokines for diagnosis of Buruli ulcer disease and as potential indicator for disease progression.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c01cd615597a8f8838fe67e289756422"><gtr:id>c01cd615597a8f8838fe67e289756422</gtr:id><gtr:otherNames>Nausch N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>58ba80a4073fd9.89419264</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>363D41F1-090D-4D59-A129-D471269DC755</gtr:id><gtr:title>Adhesion of the ulcerative pathogen Mycobacterium ulcerans to DACC-coated dressings.</gtr:title><gtr:parentPublicationTitle>Journal of wound care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/921fcb79ee4e5f0d1f6ceb07450f39a2"><gtr:id>921fcb79ee4e5f0d1f6ceb07450f39a2</gtr:id><gtr:otherNames>Geroult S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0969-0700</gtr:issn><gtr:outcomeId>545f4e71442e30.09799354</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28C7BC6A-82A9-49C8-8A80-B0F011CD4F1C</gtr:id><gtr:title>Pulmonary aspergilloma: An evasive disease.</gtr:title><gtr:parentPublicationTitle>International journal of mycobacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03be67a89affe7103c0052bb4b4a5187"><gtr:id>03be67a89affe7103c0052bb4b4a5187</gtr:id><gtr:otherNames>Ofori A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2212-5531</gtr:issn><gtr:outcomeId>589cac63154712.99772931</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCCF350C-3507-42D0-B57B-F41A83AA755A</gtr:id><gtr:title>Buruli ulcer control in a highly endemic district in Ghana: role of community-based surveillance volunteers.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9874dfadb6a30e0af0b5ae0295e6bdfa"><gtr:id>9874dfadb6a30e0af0b5ae0295e6bdfa</gtr:id><gtr:otherNames>Abass KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn><gtr:outcomeId>545f4e718dcd12.31985458</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65003395-B819-4835-88B3-02F2F3E74F5D</gtr:id><gtr:title>Effectiveness of routine BCG vaccination on buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbfe8ebeba9605840db406a1db734a1a"><gtr:id>cbfe8ebeba9605840db406a1db734a1a</gtr:id><gtr:otherNames>Phillips RO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>56c9c827e64497.58361004</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0455269F-6CD4-4375-9F40-7349F5471896</gtr:id><gtr:title>Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3392e0f3fc7fd93d222a57a3d0a4f6f1"><gtr:id>3392e0f3fc7fd93d222a57a3d0a4f6f1</gtr:id><gtr:otherNames>Niang F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56c9c825ef9133.87159427</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FB83E99-D4F3-429A-B2DA-BEB693F80069</gtr:id><gtr:title>Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study</gtr:title><gtr:parentPublicationTitle>The Lancet Gastroenterology &amp; Hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1246a3f8d5b3aea8443da1bb525ec1ed"><gtr:id>1246a3f8d5b3aea8443da1bb525ec1ed</gtr:id><gtr:otherNames>Blach S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58bab6c0bb3411.69664639</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68BBEB0B-60D3-403D-9803-4A6695FAFF3E</gtr:id><gtr:title>A re-evaluation of the origin of hepatitis C virus genotype 2 in West Africa.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/863bc8838b53ca4f027cbde8cf52e3cd"><gtr:id>863bc8838b53ca4f027cbde8cf52e3cd</gtr:id><gtr:otherNames>Purdy MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>56c9c827bfa723.92631661</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>744F1002-7C3A-4452-93A6-576D01E50C98</gtr:id><gtr:title>Long-term responses to first-line antiretroviral therapy in HIV and hepatitis B co-infection in Ghana.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f966db23a09b19b29dbbcba992446889"><gtr:id>f966db23a09b19b29dbbcba992446889</gtr:id><gtr:otherNames>Sarfo FS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn><gtr:outcomeId>545f4f6c436a83.26462292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A54402E8-CDDF-4B87-98AD-FD1829047CE6</gtr:id><gtr:title>Historical epidemiology of hepatitis C virus in select countries-volume 4.</gtr:title><gtr:parentPublicationTitle>Journal of viral hepatitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03cc93b5e7c6d788834598c4b66e7596"><gtr:id>03cc93b5e7c6d788834598c4b66e7596</gtr:id><gtr:otherNames>Maaroufi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1352-0504</gtr:issn><gtr:outcomeId>5a9c49b378f8d7.54107493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A6669E2-EB8E-484B-A0AE-E9E73830263B</gtr:id><gtr:title>Oral treatment for patients with Buruli ulcer co-infected with HIV: think twice.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3694d87cc5dad3c37732c90959febd35"><gtr:id>3694d87cc5dad3c37732c90959febd35</gtr:id><gtr:otherNames>Klis S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>545f4e70ec79c6.50750624</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34F0F87F-CF48-4A29-885B-63F967177527</gtr:id><gtr:title>Psychometric properties of the participation scale among former buruli ulcer patients in Ghana and Benin.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73ffdd7815ff48e2bfe9d7f21246a3ae"><gtr:id>73ffdd7815ff48e2bfe9d7f21246a3ae</gtr:id><gtr:otherNames>de Zeeuw J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>56c9ce87d7fcd2.54401199</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D8826A2-8ED2-421C-A377-C0A9DB5C02CE</gtr:id><gtr:title>Persisting social participation restrictions among former Buruli ulcer patients in Ghana and Benin.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73ffdd7815ff48e2bfe9d7f21246a3ae"><gtr:id>73ffdd7815ff48e2bfe9d7f21246a3ae</gtr:id><gtr:otherNames>de Zeeuw J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>56c9ce87ac9c90.65237138</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F86F53C-BDBC-4AD6-8734-B55C79370884</gtr:id><gtr:title>Antibody screening tests variably overestimate the prevalence of hepatitis C virus infection among HIV-infected adults in Ghana.</gtr:title><gtr:parentPublicationTitle>Journal of viral hepatitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dcb726dfdbcedd1aee72ef7dd407906f"><gtr:id>dcb726dfdbcedd1aee72ef7dd407906f</gtr:id><gtr:otherNames>King S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1352-0504</gtr:issn><gtr:outcomeId>56c9cbcd926403.71018400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>918FAEBD-9049-41E3-81A5-D165AC59BCCF</gtr:id><gtr:title>Pharmacogenetic associations with plasma efavirenz concentrations and clinical correlates in a retrospective cohort of Ghanaian HIV-infected patients.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f966db23a09b19b29dbbcba992446889"><gtr:id>f966db23a09b19b29dbbcba992446889</gtr:id><gtr:otherNames>Sarfo FS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>545f4f6b9db195.24422853</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3CD6888-2060-4754-805D-280E5EA20097</gtr:id><gtr:title>A severe case of Buruli ulcer disease with pleural effusions.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f966db23a09b19b29dbbcba992446889"><gtr:id>f966db23a09b19b29dbbcba992446889</gtr:id><gtr:otherNames>Sarfo FS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>545f4e70c79211.41489621</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41ACCB41-5453-469B-B4B5-772BF51116CB</gtr:id><gtr:title>Infection with Mansonella perstans Nematodes in Buruli Ulcer Patients, Ghana.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbfe8ebeba9605840db406a1db734a1a"><gtr:id>cbfe8ebeba9605840db406a1db734a1a</gtr:id><gtr:otherNames>Phillips RO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>545f4e70a29329.11216671</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3572D1AF-FE8D-4721-9EFC-ADAAF7FEC9A1</gtr:id><gtr:title>Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli Ulcer.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cdfcacf222963d75ba899963f980a82"><gtr:id>7cdfcacf222963d75ba899963f980a82</gtr:id><gtr:otherNames>Barogui YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>589cac635d6b81.71753511</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A554B702-E8B6-4AA0-AF96-D4E933DDD865</gtr:id><gtr:title>International Encyclopedia of Public Health</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad7dc2e55cb41a87687d9d8c7a003766"><gtr:id>ad7dc2e55cb41a87687d9d8c7a003766</gtr:id><gtr:otherNames>Phillips R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:isbn>9780128037089</gtr:isbn><gtr:outcomeId>58ba7fcb28b976.63217913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2476A50-AB71-447C-90DD-99B53425893F</gtr:id><gtr:title>Genetic diversity of PCR-positive, culture-negative and culture-positive Mycobacterium ulcerans isolated from Buruli ulcer patients in Ghana.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2972d8405121ba38025b33b2830ab9b0"><gtr:id>2972d8405121ba38025b33b2830ab9b0</gtr:id><gtr:otherNames>Williamson H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545f4f6bc01e75.92763057</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CE19258-9E6D-4B38-AA20-28C307FB24B9</gtr:id><gtr:title>Clinical and bacteriological efficacy of rifampin-streptomycin combination for two weeks followed by rifampin and clarithromycin for six weeks for treatment of Mycobacterium ulcerans disease.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbfe8ebeba9605840db406a1db734a1a"><gtr:id>cbfe8ebeba9605840db406a1db734a1a</gtr:id><gtr:otherNames>Phillips RO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>545f4e6fd612d3.93951194</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA35A8CC-4130-4A45-A4AE-4787535CFB61</gtr:id><gtr:title>Simple, Rapid Mycobacterium ulcerans Disease Diagnosis from Clinical Samples by Fluorescence of Mycolactone on Thin Layer Chromatography.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f0771426262cd856c8ac581c3685fc"><gtr:id>72f0771426262cd856c8ac581c3685fc</gtr:id><gtr:otherNames>Wadagni A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>56def92da4d415.62200959</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E67D2C4F-12A3-4BDD-8537-EEABB5DCE933</gtr:id><gtr:title>Helicobacter pylori Coinfection Is Associated With Decreased Markers of Immune Activation in ART-Naive HIV-Positive and in HIV-Negative Individuals in Ghana.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/531b38c950c13959425d96ddb61b7893"><gtr:id>531b38c950c13959425d96ddb61b7893</gtr:id><gtr:otherNames>Eberhardt KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>56c9c8273b97e2.73763342</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C59232C5-BDBB-44DB-AD59-CAB3E54DFDEE</gtr:id><gtr:title>High prevalence of renal dysfunction and association with risk of death amongst HIV-infected Ghanaians.</gtr:title><gtr:parentPublicationTitle>The Journal of infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f966db23a09b19b29dbbcba992446889"><gtr:id>f966db23a09b19b29dbbcba992446889</gtr:id><gtr:otherNames>Sarfo FS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0163-4453</gtr:issn><gtr:outcomeId>545f55c3854ce7.06898697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E340A3D-BC00-4C44-BD5C-E59634E435AC</gtr:id><gtr:title>Incidence and determinants of nevirapine and efavirenz-related skin rashes in West Africans: nevirapine's epitaph?</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f966db23a09b19b29dbbcba992446889"><gtr:id>f966db23a09b19b29dbbcba992446889</gtr:id><gtr:otherNames>Sarfo FS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545f4f6c1aff28.78343981</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDD9C142-0748-4284-B8CE-1E2B07F79DF9</gtr:id><gtr:title>Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease.</gtr:title><gtr:parentPublicationTitle>Cellular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f966db23a09b19b29dbbcba992446889"><gtr:id>f966db23a09b19b29dbbcba992446889</gtr:id><gtr:otherNames>Sarfo FS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1462-5814</gtr:issn><gtr:outcomeId>56def92e06da24.40475549</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F040C3E-FF2D-4931-878C-3F92DA279F33</gtr:id><gtr:title>Strategies to manage hepatitis C virus infection disease burden-Volume 4.</gtr:title><gtr:parentPublicationTitle>Journal of viral hepatitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e896c81196aae93bd473cdc3478ffbb"><gtr:id>1e896c81196aae93bd473cdc3478ffbb</gtr:id><gtr:otherNames>Chen DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1352-0504</gtr:issn><gtr:outcomeId>5a9c49b3b039e0.35379544</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D8CAB98-FEDA-4443-93E2-15B7E16CDEE4</gtr:id><gtr:title>The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: 'The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa' by Lemoine et al.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b7a6adfc0cee3a4ffa20595b2797164"><gtr:id>8b7a6adfc0cee3a4ffa20595b2797164</gtr:id><gtr:otherNames>Stockdale AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>56c9c825b9c208.11986695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99E05938-1ED5-4BF8-A7A9-B93E4F02AA4B</gtr:id><gtr:title>High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana.</gtr:title><gtr:parentPublicationTitle>International journal of mycobacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e2ef39e486743c2ada8a08a609916681"><gtr:id>e2ef39e486743c2ada8a08a609916681</gtr:id><gtr:otherNames>Boakye-Appiah JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2212-5531</gtr:issn><gtr:outcomeId>589cac633a57d5.48702441</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F758134A-FCF1-42B1-9F18-0624B7539111</gtr:id><gtr:title>Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f966db23a09b19b29dbbcba992446889"><gtr:id>f966db23a09b19b29dbbcba992446889</gtr:id><gtr:otherNames>Sarfo FS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>545f4e707a57f4.42238233</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97C7E2E3-A227-4953-BD95-C8B5C74F029E</gtr:id><gtr:title>Hepatitis E virus infections in HIV-infected patients in Ghana and Cameroon.</gtr:title><gtr:parentPublicationTitle>Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9c2e1ae9accb90a21f3508a5f96f174"><gtr:id>d9c2e1ae9accb90a21f3508a5f96f174</gtr:id><gtr:otherNames>Feldt T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1386-6532</gtr:issn><gtr:outcomeId>545f4e6f891ab9.79016794</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D82FD2A3-456B-40C8-A9A7-6220BE55CD83</gtr:id><gtr:title>Long-term effectiveness of first-line non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in Ghana.</gtr:title><gtr:parentPublicationTitle>The Journal of antimicrobial chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f966db23a09b19b29dbbcba992446889"><gtr:id>f966db23a09b19b29dbbcba992446889</gtr:id><gtr:otherNames>Sarfo FS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-7453</gtr:issn><gtr:outcomeId>545f4f6b72df12.45456965</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D09C6879-4EC2-4445-A9EE-CB800879689F</gtr:id><gtr:title>Liver Fibrosis by Transient Elastography and Virologic Outcomes After Introduction of Tenofovir in Lamivudine-Experienced Adults With HIV and Hepatitis B Virus Coinfection in Ghana.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b7a6adfc0cee3a4ffa20595b2797164"><gtr:id>8b7a6adfc0cee3a4ffa20595b2797164</gtr:id><gtr:otherNames>Stockdale AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>56c9c827942722.99936405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A6C56EA-3318-4464-AAAE-7115F603476E</gtr:id><gtr:title>Loop-Mediated Isothermal Amplification for Laboratory Confirmation of Buruli Ulcer Disease-Towards a Point-of-Care Test.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07c4321c12e424b2a4b1e405bd92453d"><gtr:id>07c4321c12e424b2a4b1e405bd92453d</gtr:id><gtr:otherNames>Beissner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>56c9c826ded384.14530414</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B68F3279-BBE4-4AB5-B1AA-F07AE33F0931</gtr:id><gtr:title>Pain Associated with Wound Care Treatment among Buruli Ulcer Patients from Ghana and Benin.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fba773d9fe2f4a72d2068e2d57911472"><gtr:id>fba773d9fe2f4a72d2068e2d57911472</gtr:id><gtr:otherNames>Alferink M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56c9c82768f568.15775833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C978C4D-C081-4DB4-A07F-54EADC9E9E57</gtr:id><gtr:title>Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West Africa.</gtr:title><gtr:parentPublicationTitle>AIDS (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/909248d6b6860eb47b0e99fa595147d7"><gtr:id>909248d6b6860eb47b0e99fa595147d7</gtr:id><gtr:otherNames>Chadwick D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-9370</gtr:issn><gtr:outcomeId>545f5132cf3292.05510226</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E90893B3-FA0E-4F55-A313-066A11ACD250</gtr:id><gtr:title>Insertion sequence element single nucleotide polymorphism typing provides insights into the population structure and evolution of Mycobacterium ulcerans across Africa.</gtr:title><gtr:parentPublicationTitle>Applied and environmental microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82df0ae42ac5f19fde65e094d0231b87"><gtr:id>82df0ae42ac5f19fde65e094d0231b87</gtr:id><gtr:otherNames>Vandelannoote K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0099-2240</gtr:issn><gtr:outcomeId>545f4e6fb12d47.59951696</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2D22141-7A0D-4B24-811F-088E824E3D1F</gtr:id><gtr:title>Epidemiology of Mansonella perstans in the middle belt of Ghana.</gtr:title><gtr:parentPublicationTitle>Parasites &amp; vectors</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c55a76ceab1d047214bc084e0632ceb"><gtr:id>9c55a76ceab1d047214bc084e0632ceb</gtr:id><gtr:otherNames>Debrah LB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1756-3305</gtr:issn><gtr:outcomeId>589cac626e2501.81021273</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B97EB00-50B1-427B-AB4B-481DE9AF3568</gtr:id><gtr:title>Former Buruli Ulcer Patients' Experiences and Wishes May Serve as a Guide to Further Improve Buruli Ulcer Management.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0542662e01ea002c048f55193a2c8ca0"><gtr:id>0542662e01ea002c048f55193a2c8ca0</gtr:id><gtr:otherNames>Velink A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>589cac6299e2e6.23376905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55869F97-1931-423C-969A-919256811BAB</gtr:id><gtr:title>Good quality of life in former Buruli ulcer patients with small lesions: long-term follow-up of the BURULICO trial.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3694d87cc5dad3c37732c90959febd35"><gtr:id>3694d87cc5dad3c37732c90959febd35</gtr:id><gtr:otherNames>Klis S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>545f4e7121c628.11469218</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6FFDA10-00ED-4D86-9043-5B49AB2674B2</gtr:id><gtr:title>Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.</gtr:title><gtr:parentPublicationTitle>Journal of the American Heart Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be8aa26f1ec9562467cef9b7769e67a5"><gtr:id>be8aa26f1ec9562467cef9b7769e67a5</gtr:id><gtr:otherNames>Nordell AD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2047-9980</gtr:issn><gtr:outcomeId>pm_23409_29_24870935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>234B38D3-7621-4AC9-93D0-48266DFDAB89</gtr:id><gtr:title>Risk of deaths, AIDS-defining and non-AIDS defining events among Ghanaians on long-term combination antiretroviral therapy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f966db23a09b19b29dbbcba992446889"><gtr:id>f966db23a09b19b29dbbcba992446889</gtr:id><gtr:otherNames>Sarfo FS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>545f4f6c68f7f0.02255512</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A14992F-AEBF-4052-92F3-45CC2A1586D6</gtr:id><gtr:title>Buruli ulcer in Liberia, 2012.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1cc05420e4b3101e07a5ffb044d45f30"><gtr:id>1cc05420e4b3101e07a5ffb044d45f30</gtr:id><gtr:otherNames>Kollie K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>545f4f6be88bd2.66403768</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E524126D-E1F6-4CA2-86C3-8F64723A165C</gtr:id><gtr:title>Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f966db23a09b19b29dbbcba992446889"><gtr:id>f966db23a09b19b29dbbcba992446889</gtr:id><gtr:otherNames>Sarfo FS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>pm_23409_29_23516649</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACD707F6-6FF7-4D2F-B340-DA636D5926DE</gtr:id><gtr:title>Assessment and Treatment of Pain during Treatment of Buruli Ulcer.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73ffdd7815ff48e2bfe9d7f21246a3ae"><gtr:id>73ffdd7815ff48e2bfe9d7f21246a3ae</gtr:id><gtr:otherNames>de Zeeuw J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>56c9c82710f7a1.16460483</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F119FEC-288F-4690-ADF7-FE9385EEE709</gtr:id><gtr:title>Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3694d87cc5dad3c37732c90959febd35"><gtr:id>3694d87cc5dad3c37732c90959febd35</gtr:id><gtr:otherNames>Klis S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>545f4e702e1671.92482897</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06D7BA4D-E783-462B-BBA2-DF517BA56D65</gtr:id><gtr:title>Helicobacter pylori Infection Is Associated with Higher CD4 T Cell Counts and Lower HIV-1 Viral Loads in ART-Na&amp;iuml;ve HIV-Positive Patients in Ghana.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f966db23a09b19b29dbbcba992446889"><gtr:id>f966db23a09b19b29dbbcba992446889</gtr:id><gtr:otherNames>Sarfo FS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56c9c826600cb4.67654898</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F596CCB8-681A-437E-A499-41A3102C3C04</gtr:id><gtr:title>Prevalence of hepatitis D virus infection in sub-Saharan Africa: a systematic review and meta-analysis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Global health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b7a6adfc0cee3a4ffa20595b2797164"><gtr:id>8b7a6adfc0cee3a4ffa20595b2797164</gtr:id><gtr:otherNames>Stockdale AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2214-109X</gtr:issn><gtr:outcomeId>5a9c49b34d9355.87481275</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4353389C-CC21-4495-918E-0B4F410FC9E4</gtr:id><gtr:title>Tenofovir is associated with increased tubular proteinuria and asymptomatic renal tubular dysfunction in Ghana.</gtr:title><gtr:parentPublicationTitle>BMC nephrology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/451e91de250ff4e0d42768ee14ab36d7"><gtr:id>451e91de250ff4e0d42768ee14ab36d7</gtr:id><gtr:otherNames>Chadwick DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2369</gtr:issn><gtr:outcomeId>56c9c826262a88.08098134</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C50FD458-CF8E-41C7-AE84-9DC483313ABE</gtr:id><gtr:title>Combined inflammatory and metabolic defects reflected by reduced serum protein levels in patients with Buruli ulcer disease.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbfe8ebeba9605840db406a1db734a1a"><gtr:id>cbfe8ebeba9605840db406a1db734a1a</gtr:id><gtr:otherNames>Phillips RO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>545f4e7051c044.22409661</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3F9255B-2E18-4D75-A44A-79880CCCD2E0</gtr:id><gtr:title>Experiences of Pain and Expectations for Its Treatment Among Former Buruli Ulcer Patients.</gtr:title><gtr:parentPublicationTitle>The American journal of tropical medicine and hygiene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4169dec27d2283c0b28b02e667c6cb37"><gtr:id>4169dec27d2283c0b28b02e667c6cb37</gtr:id><gtr:otherNames>Woolley RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9637</gtr:issn><gtr:outcomeId>589cac62e12b92.50156181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B57DDAAB-14B0-4B9A-8352-630127054E99</gtr:id><gtr:title>High frequency of active HCV infection among seropositive cases in west Africa and evidence for multiple transmission pathways.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b0ed210d8e09e9322ab08837b6267fc"><gtr:id>5b0ed210d8e09e9322ab08837b6267fc</gtr:id><gtr:otherNames>Layden JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn><gtr:outcomeId>56c9cbcdc30f82.81851629</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83227798-0CB4-41CC-ACAE-241371D7B038</gtr:id><gtr:title>Hepatitis C in sub-saharan Africa: urgent need for attention.</gtr:title><gtr:parentPublicationTitle>Open forum infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b0ed210d8e09e9322ab08837b6267fc"><gtr:id>5b0ed210d8e09e9322ab08837b6267fc</gtr:id><gtr:otherNames>Layden JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2328-8957</gtr:issn><gtr:outcomeId>56c9cbcdf09964.30921986</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9BDB184F-ACB6-4027-90F7-ACAAA7DFA30F</gtr:id><gtr:title>Reply to &amp;quot;compliance with antimicrobial therapy for buruli ulcer&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbfe8ebeba9605840db406a1db734a1a"><gtr:id>cbfe8ebeba9605840db406a1db734a1a</gtr:id><gtr:otherNames>Phillips RO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>545f4e71696a58.66473663</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D768066-D024-49BE-854D-CC6A468247FA</gtr:id><gtr:title>Clearance of viable Mycobacterium ulcerans from Buruli ulcer lesions during antibiotic treatment as determined by combined 16S rRNA reverse transcriptase /IS 2404 qPCR assay.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ce8b14b0879d425b4e84c762f6251c1f"><gtr:id>ce8b14b0879d425b4e84c762f6251c1f</gtr:id><gtr:otherNames>Sarpong-Duah M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>5a9c49b31d6425.39474549</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/J01477X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>